{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:25:01Z","timestamp":1792679101130,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Behav Genet"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10519-015-9753-3","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T02:35:57Z","timestamp":1445222157000},"page":"228-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neurobehavioral Anomalies in the Pitx3\/ak Murine Model of Parkinson\u2019s Disease and MPTP"],"prefix":"10.1007","volume":"46","author":[{"given":"Mohammed","family":"Filali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lalonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"9753_CR1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","volume":"67","author":"D Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL (1999) Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67:492\u2013496","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9753_CR2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2008.05.017","volume":"31","author":"P Ardayfio","year":"2008","unstructured":"Ardayfio P, Moon J, Leung KK, Youn-Hwang D, Kim KS (2008) Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson\u2019s disease. Neurobiol Dis 31:406\u2013412","journal-title":"Neurobiol Dis"},{"key":"9753_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuroscience.2009.12.033","volume":"166","author":"P Ardayfio","year":"2010","unstructured":"Ardayfio P, Leung A, Park J, Hwang DY, Moran-Gates T, Choi YK, Carlezon WA Jr, Tarazi FI, Kim KS (2010) Pitx3 deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs. Neuroscience 166:391\u2013396","journal-title":"Neuroscience"},{"key":"9753_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S0317167100007575","volume":"35","author":"A Beuter","year":"2008","unstructured":"Beuter A, Hern\u00e1ndez R, Rigal R, Modolo J, Blanchet PJ (2008) Postural sway and effect of levodopa in early Parkinson\u2019s disease. Can J Neurol Sci 35:65\u201368","journal-title":"Can J Neurol Sci"},{"key":"9753_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/9780470942390.mo110165","volume":"2","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Trueman RC, Dunnett SB (2012) Assessment of motor coordination and balance in mice using the rotarod, elevated bridge, and footprint tests. Curr Protoc Mouse Biol 2:37\u201353","journal-title":"Curr Protoc Mouse Biol"},{"key":"9753_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S0033291700001872","volume":"18","author":"RG Brown","year":"1988","unstructured":"Brown RG, MacCarthy B, Gotham AM, Der GJ, Marsden CD (1988) Depression and disability in Parkinson\u2019s disease: a follow-up of 132 cases. Psychol Med 18:49\u201355","journal-title":"Psychol Med"},{"key":"9753_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2004.07.008","volume":"157","author":"TH Burne","year":"2005","unstructured":"Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157:299\u2013308","journal-title":"Behav Brain Res"},{"key":"9753_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/mds.10177","volume":"17","author":"JN Caviness","year":"2002","unstructured":"Caviness JN, Adler CH, Beach TG, Wetjen KL, Caselli RJ (2002) Small-amplitude cortical myoclonus in Parkinson\u2019s disease: physiology and clinical observations. Mov Disord 17:657\u2013662","journal-title":"Mov Disord"},{"key":"9753_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"H-C Cheng","year":"2010","unstructured":"Cheng H-C, Ulane CM, Burke RE (2010) Clinical progression in Parkinson\u2019s disease and the neurobiology of axons. Ann Neurol 67:715\u2013725","journal-title":"Ann Neurol"},{"key":"9753_CR10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2009.02.035","volume":"1266","author":"S Chintala","year":"2009","unstructured":"Chintala S, Novak EK, Spernyak JA, Mazurchuk R, Torres G, Patel S, Busch K, Meeder BA, Horowitz JM, Vaughan MM, Swank RT (2009) The Vps33a gene regulates behavior and cerebellar Purkinje cell number. Brain Res 1266:18\u201328","journal-title":"Brain Res"},{"key":"9753_CR11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.neuropharm.2004.08.020","volume":"47","author":"M D\u2019Astous","year":"2004","unstructured":"D\u2019Astous M, Morissette M, Di Paolo T (2004) Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist. Neuropharmacology 47:1180\u20131188","journal-title":"Neuropharmacology"},{"key":"9753_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbr.2007.12.024","volume":"189","author":"RM Deacon","year":"2008","unstructured":"Deacon RM, Cholerton LL, Talbot K, Nair-Roberts RG, Sanderson DJ, Romberg C, Koros E, Bornemann KD, Rawlins JN (2008) Age-dependent and independent behavioral deficits in Tg2576 mice. Behav Brain Res 189:126\u2013138","journal-title":"Behav Brain Res"},{"key":"9753_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/PL00007725","volume":"244","author":"B Dubois","year":"1997","unstructured":"Dubois B, Pillon B (1997) Cognitive deficits in Parkinson\u2019s disease. J Neurol 244:2\u20138","journal-title":"J Neurol"},{"key":"9753_CR14","doi-asserted-by":"crossref","first-page":"17712","DOI":"10.1073\/pnas.0806066105","volume":"105","author":"S Ferdinandusse","year":"2008","unstructured":"Ferdinandusse S, Zomer AW, Komen JC, van den Brink CE, Thanos M, Hamers FP, Wanders RJ, van der Saag PT, Poll-The BT, Brites P (2008) Ataxia with loss of Purkinje cells in a mouse model for Refsum disease. Proc Natl Acad Sci USA 105:17712\u201317717","journal-title":"Proc Natl Acad Sci USA"},{"key":"9753_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2003.09.014","volume":"185","author":"PO Fernagut","year":"2004","unstructured":"Fernagut PO, Diguet E, Bioulac B, Tison F (2004) MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Exp Neurol 185:47\u201362","journal-title":"Exp Neurol"},{"key":"9753_CR16","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jnr.23552","volume":"93","author":"M Filali","year":"2015","unstructured":"Filali M, Lalonde R (2015) Motor activity in young APPswe +PS1\/A246E bigenic mice as a predicting variable for memory decline. J Neurosci Res 93:948\u2013953","journal-title":"J Neurosci Res"},{"key":"9753_CR17","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24:9434\u20139440","journal-title":"J Neurosci"},{"key":"9753_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1602\/neurorx.2.3.495","volume":"2","author":"SM Fleming","year":"2005","unstructured":"Fleming SM, Fernagut PO, Chesselet MF (2005) Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2:495\u2013503","journal-title":"NeuroRx"},{"key":"9753_CR19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J, Korf HW, Deller T, Braak H, Auburger G, Nussbaum RL (2003) Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci 24:419\u2013429","journal-title":"Mol Cell Neurosci"},{"key":"9753_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","volume":"24","author":"T Gomez-Isla","year":"2003","unstructured":"Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, Schrump S, Sondel J, Kotilinek L, Day J, Schwarzschild MA, Cha JH, Newell K, Miller DW, U\u00e9da K, Young AB, Hyman BT, Ashe KH (2003) Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 24:245\u2013258","journal-title":"Neurobiol Aging"},{"key":"9753_CR21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/jnnp-2012-302263","volume":"83","author":"D Grabli","year":"2012","unstructured":"Grabli D, Karachi C, Welter ML, Lau B, Hirsch EC, Vidailhet M, Fran\u00e7ois C (2012) Normal and pathological gait: what we learn from Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83:979\u2013985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9753_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-4328(01)00275-3","volume":"125","author":"JP Hatcher","year":"2001","unstructured":"Hatcher JP, Jones DNC, Rogers DC, Hatcher PD, Reavill C, Hagan JJ, Hunter AJ (2001) Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 125:43\u201347","journal-title":"Behav Brain Res"},{"key":"9753_CR23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/ejn.12150","volume":"37","author":"A Heuer","year":"2013","unstructured":"Heuer A, Vinh NN, Dunnett SB (2013) Behavioural recovery on simple and complex tasks by means of cell replacement therapy in unilateral 6-hydroxydopamine-lesioned mice. Eur J Neurosci 37:1691\u20131704","journal-title":"Eur J Neurosci"},{"key":"9753_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28:24\u201330","journal-title":"Mov Disord"},{"key":"9753_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","volume":"114","author":"DY Hwang","year":"2003","unstructured":"Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS (2003) Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Mol Brain Res 114:123\u2013131","journal-title":"Mol Brain Res"},{"key":"9753_CR26","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","volume":"25","author":"DY Hwang","year":"2005","unstructured":"Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim K (2005) 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson\u2019s disease. J Neurosci 25:2132\u20132137","journal-title":"J Neurosci"},{"key":"9753_CR27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedbrski S (2007) Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2:141\u2013151","journal-title":"Nat Protoc"},{"key":"9753_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000353981","volume":"71","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2014","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Garc\u00eda-Mart\u00edn E, Alonso-Navarro H, Ag\u00fandez JA (2014) PITX3 and risk for Parkinson\u2019s disease: a systematic review and meta-analysis. Eur Neurol 71:49\u201356","journal-title":"Eur Neurol"},{"key":"9753_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pbb.2004.02.001","volume":"78","author":"SK Kaasinen","year":"2004","unstructured":"Kaasinen SK, Oksman M, Alhonen L, Tanila H, J\u00e4nne J (2004) Spermidine\/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment. Pharmacol Biochem Behav 78:35\u201345","journal-title":"Pharmacol Biochem Behav"},{"key":"9753_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-007-0302-x","volume":"115","author":"P Kahle","year":"2008","unstructured":"Kahle P (2008) alpha-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol 115:87\u201395","journal-title":"Acta Neuropathol"},{"key":"9753_CR31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.106.119206","volume":"322","author":"T Kawasaki","year":"2007","unstructured":"Kawasaki T, Ishihara K, Ago Y, Baba A, Matusuda T (2007) Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. J Pharmacol Exp Ther 322:274\u2013281","journal-title":"J Pharmacol Exp Ther"},{"key":"9753_CR32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2014.01.023","volume":"1552","author":"K-S Kim","year":"2014","unstructured":"Kim K-S, Kang Y-M, Kang Y, Park TS, Park HY, Kim YJ, Han BS, Kim CH, Lee CH, Ardayfio PA, Han PL, Jung BH, Kim KS (2014) Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism. Brain Res 1552:72\u201381","journal-title":"Brain Res"},{"key":"9753_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.03.028","volume":"340","author":"EA Kozina","year":"2014","unstructured":"Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-Le Goff L, Ugrumov MV (2014) Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. J Neurol Sci 340:198\u2013207","journal-title":"J Neurol Sci"},{"key":"9753_CR34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00236322","volume":"65","author":"R Lalonde","year":"1987","unstructured":"Lalonde R (1987) Motor abnormalities in Weaver mutant mice. Exp Brain Res 65:479\u2013481","journal-title":"Exp Brain Res"},{"key":"9753_CR100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pneurobio.2006.11.005","volume":"81","author":"R Lalonde","year":"2007","unstructured":"Lalonde R, Strazielle C (2007) Brain regions and genes affecting postural control. Prog Neurobiol 81:45\u201360","journal-title":"Prog Neurobiol"},{"key":"9753_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-6357(03)00013-5","volume":"63","author":"R Lalonde","year":"2003","unstructured":"Lalonde R, Eyer J, Wunderle V, Strazielle C (2003) Characterization of NFH-LacZ transgenic mice with the SHIRPA primary screening battery and tests of motor function. Behav Proc 63:9\u201319","journal-title":"Behav Proc"},{"key":"9753_CR36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.physbeh.2005.06.028","volume":"86","author":"R Lalonde","year":"2005","unstructured":"Lalonde R, Marchetti N, Strazielle C (2005a) Primary neurologic screening and motor coordination of Dstdt-J mutant mice (dystonia musculorum) with spinocerebellar atrophy. Physiol Behav 86:46\u201351","journal-title":"Physiol Behav"},{"key":"9753_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbr.2004.06.020","volume":"157","author":"R Lalonde","year":"2005","unstructured":"Lalonde R, Dumont M, Staufenbiel M, Strazielle C (2005b) Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res 157:91\u201398","journal-title":"Behav Brain Res"},{"key":"9753_CR38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.brainresrev.2008.02.001","volume":"58","author":"FJS Lee","year":"2008","unstructured":"Lee FJS, Liu F (2008) Genetic factors involved in the pathogenesis of Parkinson\u2019s disease. Brain Res Rev 58:354\u2013364","journal-title":"Brain Res Rev"},{"key":"9753_CR39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.brainres.2012.11.010","volume":"149","author":"L Li","year":"2013","unstructured":"Li L, Qiu G, Ding S, Zhou F-M (2013) Serotonin hyperinnervation and upregulated serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice. Brain Res 149:236\u2013250","journal-title":"Brain Res"},{"issue":"20","key":"9753_CR40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(82)92797-0","volume":"2","author":"CD Marsden","year":"1982","unstructured":"Marsden CD (1982) Basal ganglia disease. Lancet 2(20):1141\u20131147","journal-title":"Lancet"},{"key":"9753_CR41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000180268","volume":"16","author":"YC Martins","year":"2009","unstructured":"Martins YC, Carvalho LJ, Daniel-Ribeiro CT (2009) Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Neuroimmunomodulation 16:134\u2013145","journal-title":"Neuroimmunomodulation"},{"key":"9753_CR42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.nbd.2011.12.040","volume":"46","author":"K McDowell","year":"2012","unstructured":"McDowell K, Chesselet M-F (2012) Animal models of the non-motor features of Parkinson\u2019s disease. Neurobiol Dis 46:597\u2013606","journal-title":"Neurobiol Dis"},{"key":"9753_CR43","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/srep01393","volume":"3","author":"C Noelker","year":"2013","unstructured":"Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, Breloer M, Henze C, Depboylu C, Skrzydelski D, Michel PP, Dodel RC, Lu L, Hirsch EC, Hunot S, Hartmann A (2013) Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 3:1393","journal-title":"Sci Rep"},{"key":"9753_CR44","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","volume":"100","author":"I Nunes","year":"2003","unstructured":"Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP (2003) Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci USA 100:4245\u20134250","journal-title":"Proc Natl Acad Sci USA"},{"key":"9753_CR45","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2003","unstructured":"Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, Hirst WD, Dunlop J (2003) Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS One 8:e70274","journal-title":"PLoS One"},{"key":"9753_CR46","doi-asserted-by":"crossref","first-page":"12802","DOI":"10.1523\/JNEUROSCI.0898-11.2011","volume":"31","author":"C Peng","year":"2011","unstructured":"Peng C, Aron L, Klein R, Li M, Wurst W, Prakash N, Le W (2011) Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons. J Neurosci 31:12802\u201312815","journal-title":"J Neurosci"},{"key":"9753_CR47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2013.12.054","volume":"561","author":"G Qiu","year":"2014","unstructured":"Qiu G, Fu C, Liang GH (2014) Association between PITX3 promoter polymorphism and risk of Parkinson\u2019s disease: the impact of ethnicity and onset age. Neurosci Lett 561:128\u2013133","journal-title":"Neurosci Lett"},{"key":"9753_CR48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s003350010149","volume":"11","author":"JA Rafael","year":"2000","unstructured":"Rafael JA, Nitta Y, Peters J, Davies KE (2000) Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmdmdx and Dmdmdx3cv dystrophin-deficient mice. Mamm Genome 11:725\u2013728","journal-title":"Mamm Genome"},{"key":"9753_CR49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-4328(99)00072-8","volume":"105","author":"DC Rogers","year":"1999","unstructured":"Rogers DC, Jones DNC, Nelson PR, Jones CM, Quilter CA, Robinson TL, Hagan JJ (1999) Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105:207\u2013217","journal-title":"Behav Brain Res"},{"key":"9753_CR50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(01)01885-7","volume":"306","author":"DC Rogers","year":"2001","unstructured":"Rogers DC, Peters J, Martin JE, Ball S, Nicholson SJ, Witherden AS, Hafezparast M, Latcham J, Robinson TL, Quilter CA, Fisher EM (2001) SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci Lett 306:89\u201392","journal-title":"Neurosci Lett"},{"key":"9753_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00335-009-9235-0","volume":"21","author":"M Rosemann","year":"2010","unstructured":"Rosemann M, Ivashkevich A, Favor J, Dalke C, H\u00f6lter SM, Becker L, R\u00e1cz I, Bolle I, Klempt M, Rathkolb B, Kalaydjiev S, Adler T, Aguilar A, Hans W, Horsch M, Rozman J, Calzada-Wack J, Kunder S, Naton B, Gailus-Durner V, Fuchs H, Schulz H, Beckers J, Busch DH, Burbach JP, Smidt MP, Quintanilla-Martinez L, Esposito I, Klopstock T, Klingenspor M, Ollert M, Wolf E, Wurst W, Zimmer A, de Angelis MH, Atkinson M, Heinzmann U, Graw J (2010) Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 (416insG) mice. Mamm Genome 21:13\u201327","journal-title":"Mamm Genome"},{"key":"9753_CR52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbr.2009.12.014","volume":"208","author":"TN Sager","year":"2010","unstructured":"Sager TN, Kirchhoff J, M\u00f8rk A, Van Beek J, Thirstrup K, Didriksen M, Lauridsen JB (2010) Nest building performance following MPTP toxicity in mice. Behav Brain Res 208:444\u2013449","journal-title":"Behav Brain Res"},{"key":"9753_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RK, Huston JP (2001) Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 125:109\u2013125","journal-title":"Behav Brain Res"},{"key":"9753_CR54","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/hmg\/9.11.1575","volume":"9","author":"EV Semina","year":"2000","unstructured":"Semina EV, Murray JC, Reiter R, Hrstka RF, Graw J (2000) Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum Mol Genet 9:1575\u20131585","journal-title":"Hum Mol Genet"},{"key":"9753_CR55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/brb3.235","volume":"4","author":"EA Skillings","year":"2014","unstructured":"Skillings EA, Wood NI, Morton AJ, Rogers DC (2014) Beneficial effects of environmental enrichment and food entrainment in the R6\/2 mouse model of Huntington\u2019s disease. Brain Behav 4:675\u2013686","journal-title":"Brain Behav"},{"key":"9753_CR56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00441-004-0943-1","volume":"318","author":"MP Smidt","year":"2004","unstructured":"Smidt MP, Smits SM, Burbach JP (2004) Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra. Cell Tissue Res 318:35\u201343","journal-title":"Cell Tissue Res"},{"key":"9753_CR57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.mcn.2005.07.018","volume":"30","author":"SM Smits","year":"2005","unstructured":"Smits SM, Mathon DS, Burbach JP, Ramakers GM, Smidt MO (2005) Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system. Mol Cell Neurosci 30:352\u2013363","journal-title":"Mol Cell Neurosci"},{"key":"9753_CR58","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","volume":"61","author":"K Tipton","year":"1993","unstructured":"Tipton K, Singer T (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61:1191\u20131206","journal-title":"J Neurochem"},{"key":"9753_CR59","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1242\/dev.00464","volume":"130","author":"P Munckhof van den","year":"2003","unstructured":"van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF, Drouin J (2003) Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130:2535\u20132542","journal-title":"Development"},{"key":"9753_CR60","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","volume":"20","author":"H Putten van der","year":"2000","unstructured":"van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G (2000) Neuropathology in mice expressing human alpha-synuclein. J Neurosci 20:6021\u20136029","journal-title":"J Neurosci"},{"key":"9753_CR61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oxfordjournals.jhered.a107667","volume":"59","author":"DS Varnum","year":"1968","unstructured":"Varnum DS, Stevens LC (1968) Aphakia, a new mutation in the mouse. J Hered 59:147\u2013150","journal-title":"J Hered"},{"key":"9753_CR62","doi-asserted-by":"crossref","first-page":"e111432","DOI":"10.1371\/journal.pone.0111432","volume":"9","author":"K Wada","year":"2014","unstructured":"Wada K, Matsushima Y, Tada T, Hasegawa S, Obara Y, Yoshizawa Y, Takahashi G, Hiai H, Shimanuki M, Suzuki S, Saitou J, Yamamoto N, Ichikawa M, Watanabe K, Kikkawa Y (2014) Expression of truncated PITX3 in the developing lens leads to microphthalmia and aphakia in mice. PLoS One 9:e111432","journal-title":"PLoS One"},{"key":"9753_CR101","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","volume":"83","author":"RN Walsh","year":"1976","unstructured":"Walsh RN, Cummins RA (1976) The open-field test: a critical review. Psychol Bull 83:482\u2013504","journal-title":"Psychol Bull"}],"container-title":["Behavior Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10519-015-9753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10519-015-9753-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10519-015-9753-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T21:35:19Z","timestamp":1718141719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10519-015-9753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["9753"],"URL":"https:\/\/doi.org\/10.1007\/s10519-015-9753-3","relation":{},"ISSN":["0001-8244","1573-3297"],"issn-type":[{"value":"0001-8244","type":"print"},{"value":"1573-3297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}